Agilent Technologiesvs.Thermo Fisher Scientific
A vs TMO · both in Life science tools, part of the Medicine, pharma & life science value chain: Instruments, reagents and equipment for research, development and production.
Thermo Fisher Scientific is about 5.4× larger than Agilent Technologies by market cap; year to date, Agilent Technologies leads (+12.8% vs +8.5%).
Side by side
| A | TMO | |
|---|---|---|
| Market cap | $41.5B | $223B |
| Price | $154.77 | $628.15 |
| Today | +0.9% | −0.1% |
| Return YTD | +12.8% | +8.5% |
| Return 1Y | +26.1% | +25.8% |
| P/E | 29.4 | 31.9 |
| P/S | 5.7 | 4.8 |
| P/B | 5.8 | 4.2 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
Agilent TechnologiesA
Laboratory analysis is the business: LC/MS and other analytical instruments, sold with the consumables and diagnostic reagents that keep them running.
Full A profile →Thermo Fisher ScientificTMO
Analytical instruments on one side, the reagents and consumables that feed them on the other, sold to research laboratories and pharmaceutical companies. Patheon, its contract manufacturing arm, makes drugs for customers outright.
Full TMO profile →More A & TMO comparisons
Other head-to-heads in the Life science tools segment.